The unknown etiology of CFS/ME, and complications arising from its heterogeneous nature, contributes to the lack of clear evidence for pharmaceutical interventions. PubMed, 05/23/2016. (Also see Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.